Trial intelligence / Profile preview

Hemodynamic comparison of high-flow nasal oxygen versus face mask ventilation during remimazolam induction in elderly surgical patients

jRCT1032250187Not yet recruiting

Start
Jun 2025
Modality
Small Molecules
01

Overview

Open-label trial of remimazolam (2 arms). Primary endpoint: Incidence of hypotension. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on jRCT1032250187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1032250187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call